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We have shown previously that four IgG monoclonal 
autoantibodies (mAbs) reacted in ELISA with both dou­
ble-stranded (ds) DNA and peptide 83-100 of histone H3. 
The peptide 83-100 contains a cysteine residue at posi­
tion 96 and readily dimerizes at pH 7-8. We describe 
here that only the 83-100 dimers, and not the 83-100 
monomers, are recognized by the four antibodies and 
inhibit in ELISA the binding of mAbs to dsDNA. The 
equilibrium affinity constants (Ka) and kinetic rate con­
stants of two of these mAbs were measured in a biosen­
sor system. Ka values were significantly higher when 
these mAbs were tested with dsDNA as compared with 
the 83-100 dimer. Further higher K a values were meas­
ured with mononucleosomes containing DNA and his- 
tones. It is proposed that these four mAbs are directed 
against a topographic determinant formed by DNA and 
the region 83-100 of H3 present as a dimer at the surface 
of nucleosome, and that they react, although signifi­
cantly less well, with DNA and peptide dimer tested  
separately. This study provides a quantitative and ki­
netic basis to interaction betw een several antibodies 
and distinct antigenic structures and allows us to better 
understand the structural basis of apparent autoanti­
body cross-reactivity.
Numerous observations have implicated anti-DNA antibod­
ies and nucleosomal antigens in the pathology of systemic 
lupus erythematosus (1, 2). Antibodies to DNA play a major 
role in lupus nephritis, their titers correlate with disease ac­
tivity, and deposits of anti-DNA containing immune complexes 
are found in the kidneys of lupus patients. Histones, and ap­
parently also nucleosomes, can be detected within glomerular 
deposits (3-5), and anti-DNA, anti-histone, as well as anti- 
nucleosome antibodies can be eluted from kidneys of (NZB/ 
W)F1 and MRL lpr/lpr lupus mice (6, 7).
The trigger antigen giving rise to anti-DNA antibodies has 
not been strictly identified but a number of evidences strongly 
support that nucleosomes (the basic repeating unit of chroma­
tin) may represent a potential immunogen (8, 9). Nucleosome- 
specific antibodies (i.e. antibodies reacting specifically with 
conformational epitopes present at the surface of the nucleo­
some edifice, and not with DNA and histones tested separately 
(10, 11), certainly participate in immune deposition in lupus
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glomerulonephritis. The importance of these antibody subsets 
has given rise to many investigations and in particular to the 
careful study of anti-nuclear monoclonal antibody (mAb)1 char­
acteristics, During the course of a fine examination of a series 
of IgG mAbs generated from autoimmune lupus mice and char­
acterized as anti-DNA antibodies (12), we have discovered re­
cently that some of them reacted with a single histone peptide, 
namely peptide 83-100 of H32. This peptide was the only one 
out of 53 overlapping histone peptides (in H i, H2A, H2B, H3, 
and H4) to be recognized by mAbs 2, 42, 53, and 56. These 
antibodies showed no reactivity with the parent histone H3 or 
with any of the other histones. They reacted strongly, however, 
with double-stranded (ds) DNA. Other mAbs tested in parallel 
reacted only with histone (e.g. mAb 34 recognized H3 and the 
peptide 18-32 of H33 and bound nucleosomes (13)) and not 
with dsDNA or with dsDNA but with none of the histone 
proteins or histone peptides tested (e.g. mAbs 36 and 512). The 
reactivity of four mAbs, 2, 42, 53, and 56, with dsDNA and 
peptide 83-100 of H3 was intriguing enough to prompt us to 
further study their fine specificity and their respective affinity 
for dsDNA and peptide 83-100 which a priori show no obvious 
structural similarities. The aim of this work was to examine 
the structural basis of an apparent cross-reaction on a quanti­
tative basis by measuring kinetic rate constants for the differ­
ent antigens and try to better understand the fine specificity of 
anti-nucleosome/anti-DNA autoantibodies.
MATERIALS AND METHODS
Monoclonal A n tibod ies—The reactivity of several mAbs will be de­
tailed in th is  study. They are  mAbs 2, 42, 53, and 56, which have been 
generated from (NZB/WJFI mice th a t  spontaneously develop lupus or 
from graft-uersus-host disease mice th a t  following the  injection of allo­
genic T cells from a p a re n t  s tra in ,  also develop an  autoim m une disease 
very similar to systemic lupus ery them atosus affecting patients. The 
production of these mAbs has  been described previously an d  designed 
as anti-dsDNA antibodies (12). Two of th e m  (namely mAbs 42 and 56) 
were strongly positive in  the F a r r  assay, indicating their high affinity 
for dsDNA. mAb 34 used in th is  study as control was initially obtained 
in  th e  same panel of 60 mAbs, and  its  specificity has  been recently 
described3 (13). mAbs 36 an d  51 are control anti-dsDNA antibodies.2 
mAbs 34, 36, 42, and 56 are  IgG2a, and mAbs 2, 51, and 53 Eire IgG2b. 
mAbs used in  this s tudy  were all carefully purified from culture super­
na tan t ,  as it is known th a t  nucleosomal m ateria l,  DNA, and  histones
1 The abbreviations used  are: mAb, monoclonal antibody; ELISA, 
enzyme-1 inked im m unosorbent assay; HPLC, high pressure  liquid chro­
matography; RU, resonance units; PBS, phosphate-buffered saline; 
RAM, rabbit anti-mouse.
2 K. K ram ers, C. Stem m er, S. M uller, M. C. J. van  Bruggen, G. P. M. 
Rijke, M. N. Hylkema, W. J .  M. Tax, R. J. T. Smeenk, and  J. H. M, 
Berden, subm itted  for publication.
3 K. Kramers, C. Stem mer, M. Monestier, M. C. J. van Bruggen, T. P. 
M. Rijke-Schilder, M. N. Hylkema, R. J. T. Smeenk, S. Muller, and J. H. 
M. Berden, subm itted  for publication.
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can rem ain bound to antibodies that have not been treated accordingly 
(14-16). Purification of mAbs was performed as described previously 
(Kef. 13; procedure 3). Fab fragments 56 were prepared by digestion of 
mAb 56 with papain and purified by protein A-Sepharose chromatog­
raphy. Their purity was checked by HPLC.
Nucleosomes, Hint ones, a n d  Histone Peptides — Calf thymus nuclei 
were prepared as described previously (17). They were resuspended in 
15 mM Tris buffer (pH 7.8) containing 15 mM NaCl, 60 inM KC1, 5 mM 
MgCL, 1 mM CaCl2, and 0.25 m sucrose and digested at 30 QC with 
microcoeeal nuclease. The nuclei were lysed at 0 GC for 30 rnin in 1 mM 
Tris-HCl buffer (pH 7.4) containing 0.2 mM EDTA and 0.1 mM phenyl- 
methylsulfonyl fluoride. After centrifugation (10 min at 4,000 x g  at 
4 °C), 150-200 units of digested chromatin (supernatant fraction) 
were layered on 5-29% (w/v) sucrose gradients buffered in 10 mM 
Tris-HCl (pH 7.4), 0.2 mM EDTA, 0.2 mM EGTA, and 0.1 mM phenyl- 
methylsulfonyl fluoride and centrifuged for 21 h at 4 °C in a SW28 
Beckman rotor a t  25,000 rpm. The gradients were fractionated (0.5 
ml/fraction), and the absorbance (260 nm) of each fraction was meas­
ured. The preparations were then characterized by 2% agarose gel 
electrophoresis, and fractions containing mononucleosomes were pooled 
and kept at 4 DC for a maximum of 5 days. They were never frozen. The 
content in histones of each nucleosome preparation was checked by 15% 
polyacrylamide electrophoresis.
Histone H3 used in this study was obtained from calf thymus and 
purified as described (18). I ts  purity was assessed by 18% polyacryl­
amide electrophoresis. Peptide 83-100 of H3 has been described in 
previous studies (18, 19). Peptides partially overlapping the sequence 
83-100, namely peptides encompassing residues 79-92, 91-104, and 
98-112 of H3, were also used (Table I). Calf thymus sequences were 
used for all syntheses. The purity of all peptides was assessed by 
analytical HPLC on a nucleosil C8 column, 5 jam (3.9 x 15 mm), using 
a tri ethyl ammonium phosphate buffer system. Peptides were purified 
using a medium pressure chromatography apparatus. Amino acid anal­
ysis and electrospray mass spectra showed that the purified peptides 
had the expected composition. Dimers of H3 peptides 83-100, 91-104, 
and 98-112 were prepared by dissolving peptides in phosphate-buff­
ered saline (PBS) (pH 7.6) containing 2% (v/v) dimethyl sulfoxide as 
oxidizing agent and keeping the solution a t  air and at room tempera­
ture for 3 -4  days before use. The presence of dimers was checked by 
HPLC, and the products were analyzed by fast atom bombardment 
mass spectrometry. The dimer solution was stable for at least 2 months.
Enzyme-linked Immunosorbent Assay (ELISA) —The direct ELISA 
procedure used to measure the binding of mAbs was as described 
previously (20) using plates coated with 100 ng/ml H3 in 0.05 m car­
bonate buffer pH 9.6 or with 2 /xm  of the various peptides dissolved in 
the same buffer. For the test of DNA-reacting antibodies, the plates 
were coated with 100 ng/ml dsDNA (Sigma, D4764) treated by nuclease 
S i  and dissolved in 0.025 m  citrate buffer, pH 4.4. Single stranded (ss) 
DNA was prepared from nucleosomal DNA which has been extracted by 
proteinase K trea tm ent and phenol-chloroforme precipitation followed 
by boiling 5 min a t  95 °C and cooling on ice to separate DNA strands.
For competition experiments, various concentrations of the peptides 
or DNA used as inhibitors were incubated for 1 h at 37 °C and then 
overnight at 4 °C with mAbs diluted in PBS containing 0,05% Tween 
(PBS-T). The mixtures were then added to peptide or dsDNA-coated 
wells, and the test was performed as described (20).
Kinetic Analysis o f  mAb B inding— For real time binding experi­
ments, a  BIAcore™ biosensor system (Pharmacia Biosensor, AB, Upp­
sala, Sweden) was used. Certain experiments were performed with the 
BIAcore 2000 apparatus. Reagents including sensor chips CM5, HBS 
buffer (10 mM Hepes with 0.15 M NaCl, 3.4 mM EDTA, and 0.005% 
surfactant P20 (pH 7.4)), amine coupling kit containing N-hydroxysuc- 
cimide, iV-ethyl-AT'-O-dimethylaminopropyDcarbodiimide, and ethanol- 
amine HC1, and rabbit anti-mouse Fc (RAM Fc) antibody were from 
Pharm acia Biosensor. Immobilization of the free peptides to the sensor 
chip via primary amine groups was performed according to standard 
procedures (21) with a  few modifications. The carboxylated matrix of 
the CMS sensor chip was first activated with 50 /xl of N-ethyl“iV'-(3- 
dimethylaminopropyDcarbodiimide/iV-hydroxysuccimide mixture (flow 
ra te  5 /xl/min), Dimerized peptide 83-100 of H3 (20 /xl) a t a  concentra­
tion of 500 jug/m l in 10 mM formate buffer, final pH 3.3, was injected at 
a  flow of 2 /xl/min on the sensor chip (the pH used for this step was a 
critical parameter). Approximately 100 pg of peptide were immobilized 
per mm2 (corresponding to 100 resonance units, RU). Successive injec­
tions of ethanol amine (35 /xl) and 0.1 m  HC1 (5 /xl) were then performed 
a t  a  flow of 5 ¡iVmin. The protocol used to immobilize dsDNA was 
adapted from the procedure described by Nilsson et a l  (22). The sensor 
chip was first treated by injecting successively 40 /xl of N-ethyl-N'-(3-
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F ig . 1. R ecogn ition  in  c o m p e t i t iv e  ELISA  o f  DNA a n d  83-100 
d im e r  by  mAb 56. Microtiter plates were coated with 10 ng/ml dsDNA 
and allowed to react with mAbs 51 and 56 (50 ng/ml) preincubated with 
a large excess of ss- and dsDNA (500 ng/ml) or various peptides (100 
Mg/ml) as inhibitor. Inhibitor peptides were peptides 79-92, 83-100, 
91-104, and 98-112 used as monomers (M) or dimers CD).
dimethylaminopropyl)carbodiimide/N-hydroxysuccimide mixture, 40 /xl 
of streptavidin (200 /xg/ml; Sigma, catalog number S4762) in 10 mM 
acetate buffer (pH 4.5) and 35 /xl of ethanol amine (flow rate: 5 /xl/min). 
In these conditions the chip was coated with approximately 5000 RU, 
i.e, 5 ng of streptavidin/mm.2 The sensor chip was then treated  with five 
pulses of 0.1 M sodium hydroxide (5 fxVpulse at a flow of 5 /xl/min). Five 
/xl of biotinylated DNA (Life Technologies, Inc., catalog number 15616- 
014; 4>X174 DNA-iftnfl fragments containing 1 molecule of bio tin/mol­
ecule; average length, 260 bp) a t  a concentration of 100 /xg/ml in HBS 
buffer containing 0.3 m NaCl and without P20, were then injected at a 
flow of 2 /xl/min on the streptavidin precoated chip. This procedure 
allowed about 20 RU (20 pg of DNA/mm2) to be immobilized on the chip. 
The surface was then washed with 5 /xl of HBS containing 0.05% (v/v) 
SDS. To study the binding of mAbs to mononucleosome, mAbs were 
immobilized by trapping them on sensor chips containing covalently 
bound RAM Fc according to the m anufacturer’s instructions. The bind­
ing experiments (pulses with the various analytes used between 1 and 
250 nM on the specific surfaces) were performed at 25 °C and at a flow 
rate of 5, 10, and 40 /xl/min. Antibody concentrations were determined 
according to Karls son et ah (23). Injection times were from 4 to 8 min, 
and the postinjection phase duration was 10 min. Conditions used were 
established to avoid mass transport effects (24). The regeneration step 
was optimalized for each antigen. The surfaces were thus regenerated 
during 1 min with 10 mM acetate buffer (pH 6) in the case of the matrix 
with peptide dimer, HBS containing 0.05% SDS and P20 in the case of 
the dsDNA matrix and 0.1 M HC1 in the case of the RAM Fc matrix. 
Both the procedure used to measure the antibody kinetic constants and 
the theory of kinetic measurements using the BIAcore biosensor system 
have been reviewed recently (25).
RESULTS
In our former study dealing with the characterization of the 
four mAbs 2, 42, 53, and 56,2 direct ELISA format was used in 
which dsDNA, histones, and histone peptides were directly 
adsorbed to plastic solid phase. In Fig. 1, we show the results of 
inhibition experiments performed by using dsDNA as coated 
antigen and several peptides covering the region 79-112 of H3 
(Table I) as fluid phase competitors. These peptides partially 
overlap the region 83-100. During the course of this study, we 
found that mainly dimers of peptide 83-100, and not monomers 
of this peptide, were significantly able to inhibit the reaction of 
mAbs to dsDNA (as exemplified with mAb 56 in Fig. 1). Dimers 
of peptide 83-100 were obtained by dimethyl sulfoxide-medi­
ated disulfide formation at 20 °C and pH 7.4 (26). Monomeric
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T able  I
Sequence o f  H 3 peptides tested as monomers a n d  dimers
The cysteine residue 96 is conserved in hum an, bovine, and murine 
H3. I t  is replaced by a  serine residue in  other species such as birds and 
fishes.
79 96 112
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79 92
83 100
91 104
98 112
peptides 79-92, 91-104, and 98-112 and dimers of peptides 
91-104 and 98-112 inhibited weakly (<30%) or not at all the 
antibody reaction to dsDNA (Fig. 1). This inhibition was not 
observed with mAbs 36 and 51, which react with dsDNA but 
not with 83-100 dimers (Fig. 1),
Thus, the 83-100 dimer efficiently competes with DNA for 
the binding of mAbs to dsDNA. Reciprocally, we found that the 
binding of mAbs 2, 42, 53, and 56 to 83-100 peptide dimers 
could be very efficiently inhibited by dsDNA (Fig. 2). Up to 
nearly 100% inhibition was reached with about 5-25 ng/ml 
competitor dsDNA (according to mAbs), both when dsDNA was 
used as antigen and competitor (Fig. 2A) and when dsDNA was 
used to inhibit the binding of antibodies to the 83-100 dimer 
(Fig. 2B).
These results clearly indicate that four mAbs are able to 
react with both dsDNA and a unique peptide structure con­
tained in the 83-100 dimer. The fact that 91-104 dimers 
showed much weaker activity than 83-100 dimers with mAbs 
supports the conclusion that these mAbs do not only react with 
the flanking residues of the disulfide bridge.
The two mAbs, 42 and 56, were produced in larger amounts, 
extensively purified to remove all bound nuclear material, and 
their capacity to recognize dsDNA and 83-100 dimers was 
further measured in the BIAcore using either the peptide co­
valently linked to the dextran matrix through its free NH2 
terminus or biotinylated dsDNA fragments immobilized onto 
the biosensor surface covalently precoated with streptavidin. 
We also studied the reactivity of mAbs with calf thymus mono- 
nucleosomes. The BIAcore biosensor system based on surface 
plasmon resonance detection permits the quantitative analysis 
of biomolecular interactions in real time. One of the molecular 
partners is immobilized on a dextran matrix coupled to a thin 
gold film, while the other one is introduced in a continuous flow 
passing over the sensor surface. An optical system detects 
changes in refractive index close to the metal surface, which 
allows the concentration of the reactants to be measured. The 
binding signal is continuously monitored and is translated into 
a sensorgram, expressed in RU over time. There are at least 
three major advantages of using biosensors for molecular in­
teraction measurements: (i) molecules don’t  have to be labeled, 
(ii) each step of the reaction can be directly and instanta­
neously visualized, and (iii) accurate affinity and kinetic con­
stants can be easily measured. As discussed previously (27), 
the structure of nucleosomes may be considerably altered if 
they are covalently bound to the dextran matrix on the sensor 
chip via amino groups, particularly because histone tails, 
which are very basic, play an important role in the stabilization 
of the edifice. To overcome this problem, one can either present 
nucleosomes by a first antibody (for example directed against 
one of the constitutive histones) and study the binding of an-
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F ig . 2. R ecogn ition  in  co m pe ti t iv e  ELISA o f  DNA o r  83-100 
d im er  b y  mAbs 42, 53, a n d  56. Microtiter plates were coated with 10 
ng/ml dsDNA (A) or 2 fjM 83-100 dimer (B) and allowed to react w ith  
mAbs 42 (A), 53 (□), and 56 (O) preincubated with increasing concen­
trations of dsDNA.
tibodies directed against another histone (27) or one can cap­
ture the murine mAb under study with a first antibody directed 
against mouse Ig and then pulse nucleosomes used in this case 
as analytes in the fluid phase. The latter procedure was used in 
this study with mAbs 42 and 56. Several concentrations (1-250 
nM) of nucleosomes were allowed to react with immobilized 
mAbs (300 RU), and flow rates of 5, 10, and 40 fil/min were 
used. Kinetic rate constants and equilibrium affinity constants 
of mAbs for the 83-100 dimer, dsDNA, and nucleosomes are 
shown in Table II. It appears clearly that in the BIAcore sys­
tem, both mAbs 42 and 56 preferentially bound dsDNA com­
pared with the 83-100 dimer. The equilibrium affinity con­
s ta n ts ,^ , of mAbs 42 and 56 were, respectively, 13 and 7 times 
higher for dsDNA as compared with the 83-100 dimer. In both 
cases, this was essentially due to a higher association rate 
constant, ka. Interestingly, mAbs 42 and 56 were found to 
strongly react with nucleosomes. Equilibrium affinity values 
Ka of both mAbs 42 and 56 for calf thymus mononucleosomes 
were 2.7 X 1010 m’ 1, i.e. 25 and 15 times higher than ifa values 
measured for dsDNA, and 332 and 102 times higher than K a 
values measured for the 83-100 dimer. As compared with bind­
ing to dsDNA, this increase in Ka values was mainly due to 
lower ka values. In a control experiment performed with mAb 
56, we found that when presented by RAM Fc, this mAb, as in 
direct ELISA format, did not recognize H3 or H3 dimers used 
as ligands. Reciprocally, mAb 56 used as ligand did not bind H3 
covalently linked to the dextran matrix.
A few experiments were performed with Fab fragments pre­
pared from mAb 56. We found that the respective Ka values of 
Fab 56 for the 83-100 dimer and dsDNA were six to seven 
times lower (i.e. 37 X 106 and 300 X 106 M” 1) than the Ka 
values (270 X 106 and 1870 X 10 6 M” 1) of mAb 56 for these 
antigens. Constants ka were of the same order; the lowered Ka 
values were due to higher kd values as to be expected when 
monovalent binding occurs. In both cases, was thus the asso­
ciation of mAb 56 with the 83-100 dimer and dsDNA essen­
tially bivalent, and strictly speaking, it was “avidity” rather 
than “affinity” of antibody that was measured in this study.
In a further study using the BIAcore system, we confirmed 
that the same antibody population bound dsDNA and 83-100 
dimer. mAb 56 was first allowed to react with the 83-100 dimer 
and then recovered by injecting 10 mM acetate buffer (pH 6). 
These antibodies were immediately reinjected on a sensor chip 
presenting dsDNA, and expected RU could be measured.
We could exclude the possibility that Fc domains were in­
volved in the antibody binding as in the three assays described 
(plates with DNA or 83-100 dimer and chips with nucleosome), 
RAM Fc was used to reveal bound mAbs or to capture bound
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Table II
Kinetic rate constants and equilibrium affinity constants o f mAbs 42 
and 56 for the 83-100 dimer, dsDNA, and monunucleosomes
Association (k„i and dissociation fkr{) rate constants are the mean 
obtained in at least three independent experiments. Other mAbs used 
as control show no binding with any of these antigens. Kinetic data 
were obtained by using mAbs in the flow as analyte over the different 
ligands except in the case of nucleosomes, where the mAbs were pre­
sented by a first antibody (RAM Fc) immobilized on the dextran, and 
mononucleosomes were used as analyte. Note that the latter strategy 
was also used with the 83-100 dimer (but not with dsDNA, because it 
is not applicable as the number of available epitopes is not known), and 
this gave the same da ta  as those shown in the table.
mAb Antigen ka k(i Kn
x 10 ~:s x u f ' s "1 x io~6
&1 1 ' S '1
42 83-100 dimer 25 ± 4 308 ± 11 82
dsDNA 177 ± 37 164 ± 21 1080
Mononucleosome 137 ± 39 5 ± 0.3 27200
56 83-100 dimer 31 ± 5 114 ± 18 270
dsDNA 335 ± 28 179 ± 27 1870
Mononucleosome 135 ± 29 5 ± 0 .3 27600
mAbs. Furthermore, as described above, Fab 56, as mAb 56, 
bound both dsDNA and 83-100 dimer.
DISCUSSION
*
DNA antibodies have been shown by several investigators to 
cross-react with diverse nuclear or non-nuclear components. In 
some cases, the cross-reaction involves structures where the 
similarity can be rationalized, such as cardiolipin, which has 
two phosphate groupings approximately the same distance 
apart as those on DNA. Even in this case, it has been suggested 
that only anti-DNA antibodies of relatively low avidity exten­
sively cross-react with cardiolipin, while high-avidity antibod­
ies do not (12). More frequently, DNA antibodies reacting with 
cell-surface proteins and also with extracellular matrix pro­
teins have been described (e.g. Refs. 28-30). However, no de­
tailed kinetic affinity studies of any of these cross-reactions 
have been undertaken. Moreover, as pointed out previously, 
some of these reactivities may be mainly due to the presence of 
nucleosomal material complexed to the antibody (1).
The results described herein further establish our recent 
finding2 that several monoclonal antibodies generated from 
autoimmune mice and extensively purified react with both 
dsDNA and peptide 83-100 of H3 present as a dimer involving 
a disulfide bond linking cysteine residues 96 and provide a 
quantitative support to this apparent cross-reaction. Several 
explanations for our observations can be proposed.
First, one can argue that mAbs 2, 42, 53, and 56 can be 
ranged among the so-called polyspecific antibodies. However, 
in general, these polyreactive antibodies are of the IgM isotype, 
have affinities that tend to be low (with Ka values between 103 
and 107 m” 1; Ref. 31), and react with multiple auto antigens.
Second, an alternative explanation is that the antibodies 
bind with dsDNA and 83-100 dimers through different binding 
sites located on the antibody variable regions, in a mechanism 
of “multireactivity/5 as reviewed recently (32). We have re­
ported previously that the double reactivity of several rheuma­
toid factors for IgG and histones was related to distinct binding 
sites (33, 34). Topographic mapping of these sites was per­
formed by using the whole histones and histone peptides in 
inhibition experiments and reinforced by using murine mono­
clonal anti-idiot ope antibodies reacting with distinct idiotopes 
on the rheumatoid factors.
Third, an explanation for the specificity of monoclonal anti­
bodies examined in this study is that mAbs are directed against 
a topographic determinant constituted by a segment of DNA 
associated with an epitope normally found in the (H3-H4)2
tetramer region near the surface of the octamer core of the 
nucleosome. This hypothesis referring to a mechanism called 
“dual reactivity” (32) is supported by the finding that the an­
tibodies have a very high Ka value for nucleosome (around 
2.7 x 1010 M~l ) and lower Ka values for dsDNA and 83-100 
dimers. It is probably because the initial affinity particularly 
high with the nucleosome that reaction with parts of the orig­
inal epitope is still detectable both in ELISA and in the 
BIAcore.
In order to reinforce our assumption, we have analyzed our 
results with regards to the crystal structure of the histone 
octamer that has been resolved at 3.1 A (35-37). A close exam­
ination of the chicken octamer structure showed that the 83- 
100 domain of H3 is only partially surface-oriented.4 Residues 
83-87 define the boundaries of the path of the polypeptide as it 
emerges to and “dives away” from the surface of the octamer. 
Residues 88-100 appear to be buried in octamer and not avail­
able for surface-probing by ligand molecules, and the two H3 
residues at sites 96 are not close to each other. In the nucleo­
some model built from x-ray crystallographic data of the 
chicken octamer (35-37), the 83-87 residues are predicted to 
be located in a DNA binding area and would be under the path 
of the double helix. Thus we have difficulty in explaining how 
the mAbs can cross-react with mononucleosomes in view of the 
current nucleosome models. We can argue, however, that the 
crystal structure was obviously obtained in a chemical environ­
ment very different from the reaction conditions used with 
antibodies and involved the complete octamer and not the 
nucleosome assembly. Furthermore, it has to be pointed out 
that the crystal structure of the histone octamer was solved 
from chicken erythrocyte and not from mammal nuclear mate­
rial. In birds and fishes, the cysteine residue 96 (found in 
human, bovine, and murine H3, for example) is replaced by a 
serine residue. As we have shown that the 83-100 dimer, but 
not the 83-100 monomer, was recognized by the four mAbs 
tested in this work, it might be concluded that in mammal 
octamer, cysteine residue 96 plays an important role and that 
this region assembles in a slightly different shape compared 
with chicken. In this regard, it is interesting to note that 
cysteine 96 has been reported to be more reactive to sulfhydryl 
reagents, and for this it has been suggested that it might be 
located close to the octamer surface (38, 39).
Several authors have recently pointed out the fundamental 
role of anti-nucleosome antibodies in the pathogenesis of lupus. 
It is probable that many studies based on the use of purified 
nuclear proteins or DNA tested separately have obscured an 
important part of the antibody reactivity underestimating 
specificity for nucleosomes (10). It is possible that it is precisely 
because such subsets of antibodies are able to interact with the 
complete nucleosome structure and with individual compo­
nents of this structure that they have a pathogenic role, in 
particular in lupus nephritis (1). In view of our present knowl­
edge of the nucleosome structure, our results may further sug­
gest that nucleosomes in an abnormal conformation have trig­
gered the production of these cross-reactive antibodies.
This study presents the first detailed kinetic analysis of the 
interactions between several antibodies and apparently dis­
tinct antigenic determinants. A more definitive picture should 
be obtained by combining the present results and informations 
derived from the sequence of variable regions of these antibod­
ies (30). All these data allow us to better understand the struc­
tural basis of autoantibody reactivity. Finally, this analysis 
shows that perhaps a large number of auto antibodies defined 
as anti-dsDNA antibodies on the basis of the Farr assay (re-
4 E. N. Moudrianakis, personal communication.
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garded as the golden standard) can in fact correspond to nu- 
cleosome-specific antibodies.
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